Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2400053 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift ImmunoHorizons, 2024. Verfasst von E Chandler Church und 24 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA. Hauptthemen laut MEDLINE: Mycobacterium bovis, Skin. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Cutaneous mycobacterial infections cause substantial morbidity and are challenging to diagnose and treat. An improved understanding of the dermal immune response to mycobacteria may inspire new therapeutic approaches. We conducted a controlled human infection study with 10 participants who received 2 × 106 CFUs of Mycobacterium bovis bacillus Calmette-Guérin (Tice strain) intradermally and were randomized to receive isoniazid or no treatment. Peripheral blood was collected at multiple time points for flow cytometry, bulk RNA sequencing (RNA-seq), and serum Ab assessments. Systemic immune responses were detected as early as 8 d postchallenge in this M. bovis bacillus Calmette-Guérin–naive population. Injection-site skin biopsies were performed at days 3 and 15 postchallenge and underwent immune profiling using mass cytometry and single-cell RNA-seq, as well as quantitative assessments of bacterial viability and burden. Molecular viability testing and standard culture results correlated well, although no differences were observed between treatment arms. Single-cell RNA-seq revealed various immune and nonimmune cell types in the skin, and communication between them was inferred by ligand-receptor gene expression. Day 3 communication was predominantly directed toward monocytes from keratinocyte, muscle, epithelial, and endothelial cells, largely via the migration inhibitory factor pathway and HLA-E–KLRK1 interaction. At day 15, communication was more balanced between cell types. These data reveal the potential role of nonimmune cells in the dermal immune response to mycobacteria and the utility of human challenge studies to augment our understanding of mycobacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
- Department of Medicine, University of Washington School of Medicine, Seattle, WA.
- Seattle-King County Public Health, Seattle, WA.
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.
- Department of Microbiology, University of Washington School of Medicine, Seattle, WA.
- Duke Center for Human Systems Immunology, Duke University, Durham, NC.
ORCID-Profile: E Chandler Church, Emma Bishop, Krystle K Q Yu, Justin K Brache, Jolie M Phan, Jack Heptinstall, Kelvin Chiong, Anneta Naidoo, Valentin Voillet, Koshlan Mayer-Blackwell, Gift Nwanne, Georgia D Tomaras, M Juliana McElrath, David R Sherman, Sean C Murphy, James G Kublin, Chetan Seshadri
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDA NIH HHS
- ORFDO NIH HHS
Zitieren
APA
Church, E. C., Bishop, E., Fiore-Gartland, A., Yu, K. K. Q., Chang, M., Jones, R. M., Brache, J. K., Ballweber Fleming, L., Phan, J. M., Makatsa, M. S., Heptinstall, J., Chiong, K., Dintwe, O., Naidoo, A., Voillet, V., Mayer-Blackwell, K., Nwanne, G., Andersen-Nissen, E., Vary, J. C., …, & Seshadri, C. (2024). Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400053
Vancouver
Church EC, Bishop E, Fiore-Gartland A, Yu KKQ, Chang M, Jones RM, et al. Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400053
BibTeX
@article{Church2024,
author = {Church, E Chandler and Bishop, Emma and Fiore-Gartland, Andrew and Yu, Krystle K Q and Chang, Ming and Jones, Richard M and Brache, Justin K and Ballweber Fleming, Lamar and Phan, Jolie M and Makatsa, Mohau S and Heptinstall, Jack and Chiong, Kelvin and Dintwe, One and Naidoo, Anneta and Voillet, Valentin and Mayer-Blackwell, Koshlan and Nwanne, Gift and Andersen-Nissen, Erica and Vary, Jay C and Tomaras, Georgia D and McElrath, M Juliana and Sherman, David R and Murphy, Sean C and Kublin, James G and Seshadri, Chetan},
title = {Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2400053}
}
EUVIMED